Literature DB >> 1516001

Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates.

D E Henson1, J Albores-Saavedra, D Corle.   

Abstract

Data on patients with extrahepatic bile duct carcinomas recorded in the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute were reviewed. We analyzed the records of 1766 patients reported during a 10-year period (1977-1986). These tumors occurred primarily in older age groups and were slightly more common in males. Histologic grade, histologic types, and stage of disease are useful prognostic indicators. The 5-year survival rate for patients with Stage I disease was 11%. Although carcinomas of the extrahepatic bile ducts are better differentiated than carcinomas arising in the gallbladder, they have a less favorable prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1516001     DOI: 10.1002/1097-0142(19920915)70:6<1498::aid-cncr2820700609>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Authors:  S A Khan; B R Davidson; R Goldin; S P Pereira; W M C Rosenberg; S D Taylor-Robinson; A V Thillainayagam; H C Thomas; M R Thursz; H Wasan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 2.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

3.  Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

Review 4.  Cholangiocarcinoma and its management.

Authors:  S A Khan; A Miras; M Pelling; S D Taylor-Robinson
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

5.  Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Authors:  Ryoko Sasaki; Yuichiro Takeda; Osamu Funato; Hiroyuki Nitta; Hidenobu Kawamura; Noriyuki Uesugi; Tamotsu Sugai; Go Wakabayashi; Nobuhiro Ohkohchi
Journal:  World J Surg       Date:  2007-07-25       Impact factor: 3.352

Review 6.  Epidemiology and surgical management of intrahepatic cholangiocarcinoma.

Authors:  Han Zhang; Feng Shen; Jun Han; Yi-Nan Shen; Guo-Qiang Xie; Meng-Chao Wu; Tian Yang
Journal:  Hepat Oncol       Date:  2015-11-30

Review 7.  Photodynamic therapy for pancreatic and biliary tract carcinoma.

Authors:  Lakshmana Ayaru; Stephen G Bown; Stephen P Pereira
Journal:  Int J Gastrointest Cancer       Date:  2005

8.  Diagnosis and treatment of cholangiocarcinoma: a consensus from surgical specialists of China.

Authors:  Jian-Qiang Cai; Shou-Wang Cai; Wen-Ming Cong; Min-Shan Chen; Ping Chen; Xiao-Ping Chen; Yan-Ling Chen; Yi-Fa Chen; Chao-Liu Dai; Qiang Huang; Zhi-Yong Huang; Bo Jiang; Bin Jiang; Ke-Wei Jiang; Bo Li; Zong-Fang Li; Li-Jian Liang; Bin Liu; Hui-Chun Liu; Lian-Xin Liu; Qing-Guang Liu; Rong Liu; Ying-Bin Liu; Jian-Guo Lu; Shi-Chun Lu; Yi Lu; Yi-Lei Mao; Bin Mei; Jun Niu; Bao-Gang Peng; Xiao Qin; Yu-Dong Qiu; Guang-Yi Wang; Yao-Dong Wang; Zhi-Ming Wang; Ren-Hua Wan; Ya-Fu Wu; Bao-Cai Xing; Feng Xia; Ge-Liang Xu; Jia-Mei Yang; Xiao-Fang Yu; Yong Zeng; Yong-Yi Zeng; Bi-Xiang Zhang; Bin-Hao Zhang; Qi-Yu Zhang; Shui-Jun Zhang; Wan-Guang Zhang; Yong-Jie Zhang; Zhi-Wei Zhang; Dong Zhou; Wei-Ping Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

9.  Diagnosis, Staging, and Treatment of Cholangiocarcinoma.

Authors:  Jung-Hwan Yoon; Gregory J. Gores
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

Review 10.  Update on the management of cholangiocarcinoma.

Authors:  J R A Skipworth; M G Keane; S P Pereira
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.